Skip to content

Findings of Rheumascan in patients with rheumatoid arthritis and other arthritis-related diseases

Findings of Rheumascan in patients with rheumatoid arthritis and other arthritis-related diseases - Findings of Rheumascan in patients with rheumatoid arthritis and other arthritis-related diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014037
Enrollment
110
Registered
2014-05-28
Start date
2014-05-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatoid arthritis and other diseases which can cause wrist or finger joint symptoms

Interventions

1. rheumascan examination at the enrollment 2. rheumascan examination 3-6 months after the enrollment (if a patient can be followed up 3-6 months later and written consent is obtained) 3. radiogra

Sponsors

Tokyo Medical and Dental University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who can give written consent and fulfill either of the followings 1. 2010 ACR/EULAR RA classification criteria 2. connecitve tissue diseases other than rheumatoid arthritis 3. osteoarthritis, crystal-induced arthritis, complex regional pain syndrome 4. a patient suspected of having any of the above-mentioned diseases 5. healthy volunteers

Exclusion criteria

Exclusion criteria: 1. contraindication of ICG (history of hypersensitive reaction to ICG or iodines) 2. pregnant or breastfeeding 3. a patient considered to be inappropriate for the study by the attending physician

Design outcomes

Primary

MeasureTime frame
1. signal intensity (semi-quantitative evaluation of the signal area in each joint region) and distribution of each joint 2. signal intensity and distribution outside the joint regions

Secondary

MeasureTime frame
1. Intra- and inter-disease comparison of Rheumascan findings at the enrollement and 3-6 months later. 2. relationship between rheumascan finidings and the diagnosis 3-6 months later in cases of undetermined diagnosis at the enrollment 3. relationship between Rheumascan findings and radiographic and ultrasonographic findings 4. safety of ICG administration in all cases

Countries

Japan

Contacts

Public ContactFumio Hirano

Tokyo Medical and Dental University Department of Lifetime Clinical Immunology

hirano.rheu@tmd.ac.jp03-5803-4677

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026